The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2009
Filed:
Mar. 01, 2004
Kenichiro Kataoka, Hino, JP;
Naotaka Suzuki, Tokyo, JP;
Tomomi Kosugi, Hino, JP;
Minoru Imai, Hino, JP;
Hiroaki Makino, Hino, JP;
Mika Takakuwa, Hino, JP;
Gen Unoki, Hino, JP;
Aiko Fujino, Hino, JP;
Yasuhiro Oue, Hino, JP;
Yuko Yamakoshi, Hino, JP;
Satoshi Sugiura, Hino, JP;
Robert Dale Mitchell, Walden Essex, GB;
James Donald Simpson, Walden Essex, GB;
John Clifford Harris, Walden Essex, GB;
Joelle Le, Walden Essex, GB;
Kenichiro Kataoka, Hino, JP;
Naotaka Suzuki, Tokyo, JP;
Tomomi Kosugi, Hino, JP;
Minoru Imai, Hino, JP;
Hiroaki Makino, Hino, JP;
Mika Takakuwa, Hino, JP;
Gen Unoki, Hino, JP;
Aiko Fujino, Hino, JP;
Yasuhiro Oue, Hino, JP;
Yuko Yamakoshi, Hino, JP;
Satoshi Sugiura, Hino, JP;
Robert Dale Mitchell, Walden Essex, GB;
James Donald Simpson, Walden Essex, GB;
John Clifford Harris, Walden Essex, GB;
Joelle Le, Walden Essex, GB;
Teijin Pharma Limited, Tokyo, JP;
Abstract
The Pyrazolo[1,5-a]pyrimidine derivatives represented by formula I and their pharmaceutically acceptable salts exhibit excellent kinase inhibiting activity. Drugs comprising the compounds as effective ingredients are therefore expected to be useful as therapeutic or prophylactic agents for a protein kinase mediated disorder in which kinase is implicated, such as inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth.